Hiroyuki Yoshida
5PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 15, 2023
Adipose tissue area is a predictive biomarker for the efficacy of pegylated liposomal doxorubicin in platinum-refractory/resistant ovarian cancer.Hiroyuki Yoshida, Keiichi Fujiwara
|Jan 30, 2023
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.Eric Pujade-Lauraine, Jessica Brown, Alan Barnicle
|Aug 11, 2021
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.Keiichi Fujiwara, Hiroyuki Fujiwara, Hiroyuki Yoshida
|Aug 14, 2017
Feasibility and response to nedaplatin monotherapy in older patients with ovarian cancer.Hiroyuki Yoshida, Daisuke Shintani, Aiko Ogasawara
|Dec 14, 2016
Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study.Tadaaki Nishikawa, Kosei Hasegawa, Akira Yabuno
Pageof 1
Frequent Collaborators
2 joint publications
Keiichi Fujiwara
2 joint publications
Isabelle Ray-Coquard
2 joint publications
Eric Pujade-Lauraine
1 joint publications
Tadaaki Nishikawa
1 joint publications
Kosei Hasegawa
1 joint publications
Akira Yabuno
1 joint publications
Masanori Yasuda
1 joint publications
Eito Kozawa
1 joint publications
Dominique Berton
1 joint publications
Toyomi Satoh
